Regulatory approval Archives

News and Trends 2 Oct 2020

Huge €62M Series B Boost for Mosa Meat’s Cell-Based Burgers

The Netherlands-based food technology company Mosa Meat has raised €62M in a Series B round that will be used to bring its cultured beef products a step closer to the market. The funding round was led by the Luxembourg firm Blue Horizon Ventures in collaboration with the Bell Food Group, M Ventures, and others. Of […]

October 2, 2020 - 3 minutesmins - By Laura Cowen

Expert Advice 23 Sep 2020

How to Invest Smart in Biotech Stocks

Anyone investing in public biotech companies will find it challenging to answer the key question: does this company have a good chance to create real value? Medical breakthroughs can result in huge revenues, but being the first to develop and commercialize technologies based on cutting-edge research inherently comes with a high risk of failure. In […]

September 23, 2020 - 12 minutesmins - By Carlos de Rojas

Interview 29 Jul 2020

Medical Cannabis: Regulatory Issues, Patient Demand, and Pricing Changes in Germany

While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis industry continues to flourish. A number of recent developments in Germany show that the demand for medicinal cannabis is growing. But the German medical cannabis industry is also facing a number of challenges, including an unmet patient demand and a […]

July 29, 2020 - 8 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 13 Jul 2020

Forbion Raises €185M to Fuel Late-Stage European Biotechs

The Dutch life sciences venture capital firm Forbion has bagged €185M in the first closing of a fund aimed at investing in late-stage European biotech companies, which often struggle to raise capital. The main mission of Forbion’s fund — named the Growth Opportunities Fund — is to invest in European life sciences companies raising their […]

July 13, 2020 - 3 minutesmins - By David Wilson

In Depth 17 Jun 2020

How is European Biotech Rising to the Covid-19 Testing Challenge?

Diagnostics have been thrown into the spotlight in the Covid-19 pandemic because of their instrumental role in preventing further infections. However, developing a test for Covid-19 isn’t an easy task. What exactly is needed to make a good Covid-19 test, and how are European biotech companies working to fill this need? While the development of […]

June 17, 2020 - 10 minutesmins - By Mark Livingstone

In Depth 1 Jun 2020

How Personal Genomics Companies Are Changing Drug Development

In recent years, companies offering direct-to-consumer genomics tests have started switching the business model and venturing into drug development. Amidst criticism on data protection and lack of transparency, personal genomics companies are leveraging their unique position to generate genomics data to strike lucrative deals with pharma companies. Thanks to cheaper data acquisition and convenient analysis, […]

June 1, 2020 - 6 minutesmins - By Timothé Cynober

News and Trends 28 May 2020

MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience

The US-based big pharma MSD has entered the race to be the first to develop an effective vaccine for Covid-19 by acquiring Austrian biotech Themis Bioscience and its vaccine technology for an undisclosed amount. MSD has been a bit slower than some of its contemporaries to announce its plans regarding a potential treatment or vaccine […]

May 28, 2020 - 3 minutesmins - By Helen Albert

News and Trends 15 May 2020

Update: ADC Therapeutics’ IPO Hits Above Target with €215M

Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York Stock Exchange far above the initial target of €172M, raising a total of €215.2M ($232.7M). ADC Therapeutics ended up offering more than 12 million shares at a price of €17.57 ($19) per share, which was higher than the €16.65 ($18) […]

May 15, 2020 - 4 minutesmins - By Laura Cowen

genmab janssen blood cancer multiple myeloma

News and Trends 14 May 2020

Oncopeptides’ Share Issue Bags €133M to Take Cancer Drug to Market

Swedish biotech Oncopeptides has raised €133M (SEK 1.4B) by issuing new company shares, surpassing expectations and driving the launch of its targeted chemotherapy drug in the US. In what could be one of European biotech’s largest equity boosts this year, the company exceeded initial plans to raise €111M (SEK 1.2M) through Nasdaq Stockholm following a […]

May 14, 2020 - 3 minutesmins - By Anita Chakraverty

BioNTech Production scaled e1584385495951

News and Trends 29 Apr 2020

Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans

Update (29/04/2020): A vaccine developed by the German company BioNTech and its big pharma partner Pfizer has become the first European mRNA vaccine for Covid-19 to enter human testing in a phase I/II trial. Since dosing began last week, twelve volunteers in Germany have been given the vaccine. The first part of the trial — […]

April 29, 2020 - 5 minutesmins - By Helen Albert

pluristem cell therapy covid 19 coronavirus

News and Trends 29 Apr 2020

Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy

Israeli cell therapy biotech Pluristem Therapeutics has secured up to €50M in non-dilutive funding from the European Investment Bank to progress its coronavirus-targeting cell therapy to phase III. The partners plan to sign the funding agreement at the end of April and Pluristem will initially receive €20M followed by two further installments totaling up to […]

April 29, 2020 - 3 minutesmins - By Helen Albert

News and Trends 6 Apr 2020

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

The UK company Izana Bioscience is freely providing its phase III-ready anti-inflammatory antibody namilumab in a compassionate use program for the treatment of patients with coronavirus disease in Italy. In severe cases of coronavirus disease, also known as Covid-19, patients experience hyperinflammation. One of the drivers of inflammation is thought to be a protein called […]

April 6, 2020 - 2 minutesmins - By David Kirk

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Regulatory approval

Huge €62M Series B Boost for Mosa Meat’s Cell-Based Burgers

How to Invest Smart in Biotech Stocks

Medical Cannabis: Regulatory Issues, Patient Demand, and Pricing Changes in Germany

Forbion Raises €185M to Fuel Late-Stage European Biotechs

How is European Biotech Rising to the Covid-19 Testing Challenge?

How Personal Genomics Companies Are Changing Drug Development

MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience

Update: ADC Therapeutics’ IPO Hits Above Target with €215M

Oncopeptides’ Share Issue Bags €133M to Take Cancer Drug to Market

Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans

Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!